Gelteq Limited Ordinary Shares (GELS) is a publicly traded Healthcare sector company. As of May 21, 2026, GELS trades at $0.46 with a market cap of $4.34M and a P/E ratio of 0.00. GELS moved +27.74% today. Year to date, GELS is -43.11%; over the trailing twelve months it is -73.39%. Its 52-week range spans $0.39 to $5.50. Rallies surfaces GELS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own GELS include Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Gelteq Limited Ordinary Shares.
| Metric | Value |
|---|---|
| Price | $0.46 |
| Market Cap | $4.34M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.50 |
| 52-Week Low | $0.39 |
| Volume | 1.95K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
GELS analyst coverage data. Average price target: $0.00.